Change to classification of MDMA and psilocybin to enable prescribing by authorised psychiatrists

Sdílet
Vložit
  • čas přidán 8. 03. 2023
  • This webinar will address the recent announcement by the Therapeutic Goods Administration (TGA) that medicines containing psilocybin and MDMA will be classified as Schedule 8 (controlled drug) in the Poisons Standard for specific conditions when prescribed by a psychiatrist under the Authorised Prescriber scheme.

Komentáře •